Receptor tyrosine kinase coactivation networks in cancer
about
Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactomeNew Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical TrialsDual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid TumorsExploiting polypharmacology for drug target deconvolutionFrequent activation of EGFR in advanced chordomas.Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy.Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo.The origins of cancer robustness and evolvability.Optical fiber-based in vivo quantification of growth factor receptors.Complexity of receptor tyrosine kinase signal processing.Nonamplified FGFR1 is a growth driver in malignant pleural mesotheliomacMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast CancerTailoring tyrosine kinase inhibitors to fit the lung cancer genome.An "omics" approach to determine the mechanisms of acquired aromatase inhibitor resistanceDiscovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation.Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β.Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity.Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation.Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase.An Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases.Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC.LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signalingThe DIONESUS algorithm provides scalable and accurate reconstruction of dynamic phosphoproteomic networks to reveal new drug targets.Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation.Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells.USP8 is a novel target for overcoming gefitinib resistance in lung cancer.Receptor tyrosine kinases and their activation in melanoma.How Förster resonance energy transfer imaging improves the understanding of protein interaction networks in cancer biology.The challenges of integrating molecular imaging into the optimization of cancer therapy.Emerging antibody combinations in oncology.Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed.Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation.Discoidin domain receptors: a proteomic portrait.Discoidin domain receptor 2 signaling networks and therapy in lung cancer.
P2860
Q24294625-1399AA46-EC01-4FF6-B626-A8D09E6D4037Q26772800-CBF52A16-75B9-4B6E-8EA8-1A850668493AQ28822011-41F0F3ED-D020-4F3E-8E95-81A48121748CQ30575524-45F64A1B-F5F3-4C4E-A044-512B8298F496Q33274473-C70D1D8F-3236-4592-90B7-A60A964FD30BQ33412198-69FE7554-4F52-4684-BC29-FAFB6E4D9894Q33652455-FD2B1B6A-3467-468A-BC04-B88FF684D3C8Q33770265-A122B6EE-84E0-4C1D-B96C-183C5C303A37Q33880064-8DAD1CBE-D8AA-4E7D-879D-25359FE4DA74Q34101045-41EF97BF-57F9-4D16-AD0E-E22DE5BB1A8CQ34143477-1222BEC5-7C45-4EFA-B72B-CA43F9C618DCQ34226408-984C2183-EC9D-44D6-84A2-38719CC98634Q34361161-6BBB7D82-10A3-43DA-AE1A-FCD7D30EAF38Q34364821-9BC42D21-5762-470C-A51D-911F3F013A29Q34438708-BF709DE1-6F0D-46B1-AC87-CCA94EB45FE4Q34754045-38231A98-E4BB-422A-849C-EA58A70B4F3AQ35075021-8D6E9C9D-64D6-45DB-B770-B783C0495276Q35080328-8718383A-7586-4A76-AC7E-97D13188E36AQ35177853-2FD3A51B-9529-42DC-98B7-B3E35D3AA75EQ35331391-E8DDFDA7-8FE5-4EB2-80EE-5776C1815464Q35341639-9A714426-CF90-4CCE-B7D0-B08F977A585AQ35390011-09CC2EAE-960A-45E0-B835-8B376B659672Q35556501-C53F0732-9763-4808-B03D-B1FF7EAC30A1Q35577672-410F0487-C743-4E4B-A612-FE196EFFCC50Q35770299-BE1A5751-5DC6-49B1-8087-366A55D543E1Q35803259-30F9FC80-8C47-4E77-A04C-9C311C2E0685Q35878760-89021909-3603-44DA-9F1C-D72F3D9CB7CDQ35927501-B59A193E-5A0C-418A-8B49-E1F6D8FB782BQ35982925-B1CCDE8C-0AD9-4C9C-A830-A40F60751E5BQ37194653-36D9FE3D-CEDF-4E5E-B882-CB2327252113Q37218007-BC92F830-6165-486A-BB5B-5A7E8D36A2C9Q37476722-334633B5-0FDD-4327-B78E-FF0B7AA33803Q37841746-8429FE7B-D1AF-4AEA-AD64-F4DF1FD1B44DQ37843988-9450D65E-BC8F-4E63-BCC3-E227D2DC8408Q37871875-FD26BDF2-98D6-4903-8CFE-65843B26FB34Q37893414-43F2B1C1-7F15-4FC0-BF48-A968553EDB80Q38138610-468255C1-FC73-48A9-A563-3BA426CB9DE5Q38184989-D8B1C1F2-624F-40FF-A0F2-2112C67258FDQ38202550-808380AB-7BC4-4175-BACD-CAEA26A7BAF9Q38211796-47210DCC-1BC6-4194-B727-6790D503A3B1
P2860
Receptor tyrosine kinase coactivation networks in cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Receptor tyrosine kinase coactivation networks in cancer
@ast
Receptor tyrosine kinase coactivation networks in cancer
@en
type
label
Receptor tyrosine kinase coactivation networks in cancer
@ast
Receptor tyrosine kinase coactivation networks in cancer
@en
prefLabel
Receptor tyrosine kinase coactivation networks in cancer
@ast
Receptor tyrosine kinase coactivation networks in cancer
@en
P2860
P1433
P1476
Receptor tyrosine kinase coactivation networks in cancer
@en
P2860
P304
P356
10.1158/0008-5472.CAN-10-0163
P407
P577
2010-04-20T00:00:00Z